This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Efavirenz and nevirapine may increase how quickly your body processes lopinavir.
What might happen:
The levels of lopinavir in your blood may decrease, making it less effective against your HIV infection.
What you should do about this interaction:
Your healthcare professionals (e.g. doctor or pharmacist) may already be aware of this interaction and may be monitoring you for it. Your doctor may want to run blood tests to make sure that your lopinavir is still working. Your doctor may want to increase the dosage of your lopinavir. Do not start, stop, or change the dosage of any medicine before checking with your healthcare professionals first.
1.Kaletra (lopinavir/ritonavir tablets) US prescribing information. Abbott Laboratories June 15, 2017.
2.Kaletra (lopinavir/ritonavir capsules) US prescribing information. Abbott Laboratories September, 2016.
3.Sustiva (efavirenz) US prescribing information. Bristol-Myers Squibb Company October, 2017.
4.Viramune (nevirapine) US prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc. March, 2017.